Macquarie Value Inst
DDVIX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- Philadelphia, PA 19103 Philadelphia PA United States of America 19103
- IPO Date
- Sep 14, 1998
- CIK
- 0000027574
- Website
- macquarie.com
- Similar Companies
- Business
- Macquarie Value Fund Institutional Class (DDVIX) is an open-ended investment company that seeks long-term capital appreciation by investing primarily in common stocks of large-capitalization value companies, defined as those with market capitalizations typically exceeding $10 billion at the time of purchase; it maintains a non-diversified portfolio concentrated in U.S. equities across sectors including financial services, technology, healthcare, industrials, and communication services, with top holdings such as Alphabet Inc., Thermo Fisher Scientific Inc., Bank of America Corp., CSX Corp., and Prologis Inc. The fund employs a value-oriented investment style, focusing on companies with superior business models, competitive advantages, and sustained growth potential; it offers daily pricing, a net expense ratio of 0.72%, and is available to U.S. investors with no minimum initial investment requirement. Launched on September 14, 1998, and domiciled in the United States, the fund is managed by a team including Nikhil Lalvani (since 2006), Erin Ksenak (since 2020), and Vincent Celentano (since February 2025), with total net assets of approximately $2.21 billion and share class size of $965.61 million as of the latest reporting. In a significant strategic development, Macquarie Asset Management divested its North American and European public investments business, including this fund, to Nomura in an approximately $2.8 billion all-cash transaction announced in April 2025, positioning the fund under Nomura's management while fostering ongoing collaboration between the firms for client benefits and alternative investment distribution. This divestiture reflects Macquarie's shift toward a focused global private markets alternatives business, with Nomura committing seed capital for Macquarie-targeted U.S. wealth market funds and enhancing its active ETF and investment solution capabilities. The transaction, expected to close in the second half of 2025, marks a major reorganization for the fund's oversight and aligns with broader industry consolidation trends in asset management. The fund operates primarily in the U.S. market, targeting institutional and retail investors seeking exposure to large-cap value equities.